How many insider declarations has McBarron Paul filed?

McBarron Paul has filed 2 public insider declarations with SEC (Form 4).

What is McBarron Paul's role?

McBarron Paul's reported role is not specified by the regulator across the filings.

Which companies does McBarron Paul report trades for?

McBarron Paul reports trades for Cyclacel Pharmaceuticals, Inc..

What is McBarron Paul's declared buy vs sell volume?

Across the available history, declared buys total 6k€ and disposals 0.

← Executives ★ Sign in to follow

MP

McBarron Paul

·SEC (Form 4)

Cyclacel Pharmaceuticals, Inc.

0

申报总数

0

公司

€5,712

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by McBarron Paul. Director active across 1 company, notably Cyclacel Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €6k. History available since 31 January 2023. The latest transaction was filed on 21 December 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to McBarron Paul

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Cyclacel Pharmaceuticals, Inc. (US)

申报2 总计

▲

McBarron Paul

See Remarks高管2023年12月21日Cyclacel Pharmaceuticals, Inc.

US$6,25226SEC ↗

1,886 股@ US$3.315100.0% 占其流量Common StockSEC:0001104659-23-129186:0

标准退出：2024年3月20日 (T+90)

◆

McBarron Paul

See Remarks高管2023年1月31日Cyclacel Pharmaceuticals, Inc.

0SEC ↗

31,200 股0Common StockSEC:0001104659-23-009914:0

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

MP

McBarron Paul

·SEC (Form 4)

Cyclacel Pharmaceuticals, Inc.

0

申报总数

0

公司

€5,712

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by McBarron Paul. Director active across 1 company, notably Cyclacel Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €6k. History available since 31 January 2023. The latest transaction was filed on 21 December 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.